CABOTIB 40MG TABLET

Form: Tablets

Pack Size: 30 TABLETS

Marketed by: GLENMARK PHARMACEUTICALS LTD (ONCOLOGY DIV)

MRP: ₹3624.00

GLENMARK PHARMACEUTICALS LTD (ONCOLOGY DIV): Cabotib 40MG Tablet, 30 tablets, salt cabozantinib 40mg. NPPA has revised its MRP from Rs 8,828.44 to Rs 3,624 (59% lower) with effect from 09-11-2026; trade rate Rs 2,761.14. Group: multi-kinase inhibitor (targeted therapy). Same salt is also supplied by Cipla, MSN. Handling/counselling: take on an empty stomach; not interchangeable with the capsule form used for thyroid cancer. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.